Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added, and the page removed the funding-status notice, Melanoma topic, related topics, and the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding impact and operational status; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedMinor UI/copy updates: glossary toggle text is added, labels are capitalized to read 'Last Update Submitted that Met QC Criteria', and the footer shows 'Revision: v3.4.0' with adjusted 'No FEAR Act Data' capitalization.SummaryDifference0.2%

- Check35 days agoChange DetectedMelanoma has been added to the related topics, and MedlinePlus Genetics is now listed under related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated to v3.3.4. Related topics Melanoma and MedlinePlus Genetics, as well as Revision: v3.3.3, were removed.SummaryDifference0.2%

- Check49 days agoChange DetectedAdded Melanoma and MedlinePlus Genetics as related topic links on the page to provide quick access to disease-related resources without altering core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.